During the past decade, Fundeni Clinical Institute - Urology Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundeni Clinical Institute - Urology Department" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundeni Clinical Institute - Urology Department" are "Clear Cell Renal Carcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Fundeni Clinical Institute - Urology Department" in a lesser frequency.

Most popular intervention types in "Fundeni Clinical Institute - Urology Department" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABR-217620/naptumomab estafenatox" (1 trials), "IFN-alpha" (1 trials), "Placebo" (1 trials), "Standard of care therapy" (1 trials) and "Trovax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundeni Clinical Institute - Urology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundeni Clinical Institute - Urology Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundeni Clinical Institute - Urology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundeni Clinical Institute - Urology Department, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".